Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 19 (10) , 770-780
- https://doi.org/10.1097/fpc.0b013e328330eeca
Abstract
Human multidrug and toxin extrusion member 1, MATE1 (SLC47A1), plays an important role in the renal and biliary excretion of endogenous and exogenous organic cations including many therapeutic drugs. In this study, we characterized the transcriptional effects of five polymorphic variants and six common haplotypes in the basal promoter region of MATE1 that were identified in 272 DNA samples from ethnically diverse US populations. We measured luciferase activities of the six common promoter haplotypes of MATE1 using in-vitro and in-vivo reporter assays. Haplotypes that contain the most common variant (mean allele frequency in four ethnic groups: 0.322), g.–66T>C, showed a significant decrease in reporter activities compared to the reference. Two transcription factors, activating protein-1 (AP-1) and activating protein-2 repressor (AP-2rep), were predicted to bind to the promoter in the region of g.–66T>C. Results from electrophoretic mobility shift assays showed that the g.–66T allele, exhibited greater binding to AP-1 than the g.–66C allele. AP-2rep inhibited the binding of AP-1 to the MATE1 basal promoter region, and the effect was considerably greater for the g.–66T>C. These data suggest that the reduced transcriptional activity of g.–66T>C results from a reduction in the binding potency of the transcriptional activator, AP-1, and an enhanced binding potency of the repressor, AP-2rep to the MATE1 basal promoter region. Consistent with the reporter assays, MATE1 mRNA expression levels were significantly lower in kidney samples from individuals who were homozygous or heterozygous for g.–66T>C in comparison with samples from individuals who were homozygous for the g.–66T allele. Our study suggests that the rate of transcription of MATE1 is regulated by AP-1 and AP-2rep and that a common promoter variant, g.–66T>C may affect the expression level of MATE1 in human kidney, and ultimately result in variation in drug disposition and response.Keywords
This publication has 28 references indexed in Scilit:
- Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport functionThe Pharmacogenomics Journal, 2009
- Krüppel-like transcription factors: A functional familyThe International Journal of Biochemistry & Cell Biology, 2008
- Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1American Journal of Physiology-Renal Physiology, 2007
- Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion FamilyThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Identification and Functional Characterization of a New Human Kidney–Specific H+/Organic Cation Antiporter, Kidney-Specific Multidrug and Toxin Extrusion 2Journal of the American Society of Nephrology, 2006
- Increased Glucose Uptake and Metabolism in Mesangial Cells Overexpressing Glucose Transporter 1 Increases Interleukin-6 and Vascular Endothelial Growth Factor Production: Role of AP-1 and HIF-1αCellular Physiology and Biochemistry, 2006
- Increased Activity of Activator Protein-1 Transcription Factor Components ATF2, c-Jun, and c-Fos in Human and Mouse Autosomal Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Nomenclature for the description of human sequence variationsHuman Genetics, 2001
- Regulation of Cytokine-Induced iNOS Expression by a Hairpin Oligonucleotide in Murine Cerebral Endothelial CellsBiochemical and Biophysical Research Communications, 1997